Evidence map›Paper›PMID 39941898›Full record

ArticleCancers2025

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Sara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino, Alejandro Martín Garcia-Sáncho, Fernando Carnicero-González, Natalia Palazón-Carrión, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Antonio Rueda-Domínguez, Natividad Martínez-Banaclocha and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sara Fernández-CastillejoTranslational, Epidemiological and Clinical Oncological Research Group (GIOTEC), Department of Oncology, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Tarragona, Spain.ORCID 0000-0002-8109-9713
Joan BadiaTranslational, Epidemiological and Clinical Oncological Research Group (GIOTEC), Department of Oncology, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Tarragona, Spain.ORCID 0000-0001-7446-7365
Luís de la Cruz-MerinoCancer Immunotherapy Group, Oncohematology and Genetics Department, Biomedicine Institute of Seville (IBIS)/CSIC, 41013 Seville, Spain.ORCID 0000-0002-5333-0535
Alejandro Martín Garcia-SánchoDepartment of Hematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-6330-1028
Fernando Carnicero-GonzálezDepartment of Hematology, San Pedro de Alcántara Hospital, 10003 Cáceres, Spain.
Natalia Palazón-CarriónCancer Immunotherapy Group, Oncohematology and Genetics Department, Biomedicine Institute of Seville (IBIS)/CSIC, 41013 Seville, Spain.ORCID 0000-0001-7698-9503
Eduardo Ríos-HerranzDepartment of Hematology, Hospital Universitario Virgen de Valme, 41014 Sevilla, Spain.
Fátima de la Cruz-VicenteDepartment of Hematology, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Antonio Rueda-DomínguezDepartment of Clinical Oncology. Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0001-5890-0149
Natividad Martínez-BanaclochaDepartment of Oncology, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-7515-5037
José Gómez-CodinaDepartment of Clinical Oncology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Jorge LabradorDepartment of Hematology, Hospital Universitario de Burgos, 09006 Burgos, Spain.ORCID 0000-0002-3696-0287
Francisca Martínez-MadueñoTranslational, Epidemiological and Clinical Oncological Research Group (GIOTEC), Department of Oncology, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Tarragona, Spain.
Núria AmigóFaculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), 43201 Reus, Tarragona, Spain.ORCID 0000-0002-0116-9145
Antonio Salar-SilvestreDepartment of Hematology, Hospital del Mar, 08003 Barcelona, Spain.
Delvys Rodríguez-AbreuDepartment of Clinical Oncology, Hospital Universitario Insular de Gran Canaria, 35016 Las Palmas de Gran Canaria, Las Palmas, Spain.
Laura Gálvez-CarvajalDepartment of Clinical Oncology. Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0002-7952-598X
Margarita Sánchez-BeatoLymphoma Research Group, Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, 28222 Majadahonda, Madrid, Spain.ORCID 0000-0002-0058-7599
Mariano Provencio-PullaDepartment of Clinical Oncology, Hospital Universitario Puerta De Hierro-Majadahonda, IDIPHISA, 28222 Majadahonda, Madrid, Spain.ORCID 0000-0001-6315-7919
Maria Guirado-RisueñoDepartment of Clinical Oncology, Hospital Universitario de Elche, 03203 Elche, Alicante, Spain.
Esteban NogalesCancer Immunotherapy Group, Oncohematology and Genetics Department, Biomedicine Institute of Seville (IBIS)/CSIC, 41013 Seville, Spain.
Víctor Sánchez-MargaletMedical Biochemistry and Molecular Biology and Immunology, Hospital Universitario Virgen de la Macarena, 41009 Sevilla, Spain.ORCID 0000-0001-8638-8680
Carlos Jiménez-CorteganaMedical Biochemistry and Molecular Biology and Immunology, Hospital Universitario Virgen de la Macarena, 41009 Sevilla, Spain.ORCID 0000-0001-6956-7740
Guillermo Rodríguez-GarcíaDepartment of Hematology, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Raquel CumerasTranslational, Epidemiological and Clinical Oncological Research Group (GIOTEC), Department of Oncology, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Tarragona, Spain.ORCID 0000-0003-4663-4247
Josep GumàTranslational, Epidemiological and Clinical Oncological Research Group (GIOTEC), Department of Oncology, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Tarragona, Spain.ORCID 0000-0001-7541-9832
Spanish Lymphoma Oncology Group (GOTEL)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3-hydroxybutyrate3OHBacetonediffuse large B-cell lymphoma (DLBCL)ketone bodiesmetabolomicsprognostic biomarkersrelapsed/refractory lymphoma

Identifiers

PMID39941898
PMCPMC11817199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.